CIK 0001453593
- Non-accelerated filer
- Smaller reporting company
Xtant Medical Holdings, Inc.
Sign in to watch- Ticker
- XTNT
- Exchange
- NYSE
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 205313323
- Phone
- +1 406-388-0480
- Business address
- 664 CRUISER LANE, BELGRADE, MT, 59714
- Former names
- Bacterin International Holdings, Inc., K KITZ INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 73 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-08-15 | Brandt Kevin D Chief Commercial Officer | Grant or award · Stock Option (right to buy) | +40,527 | 40,527 | ||
| 2019-08-15 | JENSEN GREG VP, Finance & CFO | Grant or award | +33,898 | 33,898 | ||
| 2019-08-15 | JENSEN GREG VP, Finance & CFO | Grant or award · Stock Option (right to buy) | +39,063 | 39,063 | ||
| 2019-04-01 | Rizzo Matthew Director | Grant or award · Warrant (right to buy) | +765,992 | 765,992 | ||
| 2019-04-01 | Rizzo Matthew Director | Grant or award · Warrant (right to buy) | +434,008 | 434,008 | ||
| 2019-04-01 | Eggenberg Michael Director | Grant or award · Warrant (right to buy) | +765,992 | 765,992 | ||
| 2019-04-01 | Eggenberg Michael Director | Grant or award · Warrant (right to buy) | +434,008 | 434,008 | ||
| 2019-04-01 | ORBIMED ADVISORS LLC Director | Grant or award · Warrant (right to buy) | +765,992 | 765,992 | ||
| 2019-04-01 | ORBIMED ADVISORS LLC Director | Grant or award · Warrant (right to buy) | +434,008 | 434,008 | ||
| 2019-01-15 | Berlin Ronald G. VP & Chief Operations Officer | Grant or award · Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2018-10-15 | Mainelli Michael Interim CEO | Grant or award · Stock Option (right to buy) | +240,000 | 240,000 | ||
| 2018-09-17 | Rizzo Matthew Director | Grant or award · Warrant (right to buy) | +765,992 | 765,992 | ||
| 2018-09-17 | Rizzo Matthew Director | Grant or award · Warrant (right to buy) | +434,008 | 434,008 | ||
| 2018-09-17 | Eggenberg Michael Director | Grant or award · Warrant (right to buy) | +765,992 | 765,992 | ||
| 2018-09-17 | Eggenberg Michael Director | Grant or award · Warrant (right to buy) | +434,008 | 434,008 | ||
| 2018-09-17 | ORBIMED ADVISORS LLC Director | Grant or award · Warrant (right to buy) | +765,992 | 765,992 | ||
| 2018-09-17 | ORBIMED ADVISORS LLC Director | Grant or award · Warrant (right to buy) | +434,008 | 434,008 | ||
| 2018-09-15 | Lenzen Kathie J. Chief Financial Officer | Grant or award · Stock Option (right to buy) | +130,000 | 130,000 | ||
| 2018-08-15 | Peters Jeffrey J Director | Grant or award | +26,042 | 26,042 | ||
| 2018-08-15 | O'Connell Carl Chief Executive Officer | Grant or award · Stock Option (right to buy) | +200,000 | 200,000 |
Page 10 of 19 · 371 trades